Trial Profile
Beta-2AR Polymorphysims and Albuterol Responsiveness in Acute Asthma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2023
Price :
$35
*
At a glance
- Drugs Salbutamol (Primary)
- Indications Acute asthma
- Focus Pharmacogenomic; Therapeutic Use
- 26 Aug 2021 Status changed from recruiting to completed.
- 11 May 2011 Planned end date changed from 1 Jan 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.
- 11 May 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.